pyrrolidonecarboxylic acid has been researched along with Hepatocellular Carcinoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, YX; Guo, WY; Li, RR; Liu, GZ; Liu, SY; Yang, GF; Yang, WC | 1 |
| Borro, P; Leone, S; Testino, G | 1 |
| Elgjo, K; Hall, KS; Paulsen, JE; Reichelt, KL; Rugstad, HE | 1 |
3 other study(ies) available for pyrrolidonecarboxylic acid and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Pyroglutamate Aminopeptidase I Promotes Hepatocellular Carcinoma via IL-6/STAT3 Activation as Revealed by a Specific Biosensor.
Topics: Animals; Biosensing Techniques; Carcinoma, Hepatocellular; Interleukin-6; Liver Neoplasms; Mice; Mice, Nude; Pyroglutamyl-Peptidase I; Pyrrolidonecarboxylic Acid; STAT3 Transcription Factor | 2021 |
Liver Disease and Hepatocellular Carcinoma in Alcoholics: The Role of Anticraving Therapy.
Topics: Acamprosate; Alcohol Deterrents; Alcoholics; Alcoholism; Baclofen; Carcinoma, Hepatocellular; Drug Combinations; Humans; Liver Cirrhosis; Liver Neoplasms; Pyridoxine; Pyrrolidonecarboxylic Acid; Risk Factors; Taurine | 2016 |
The synthetic hepatic peptides pyroglutamylglutamylglycylserylasparagine and pyroglutamylglutamylglycylserylaspartic acid inhibit growth of MH1C1 rat hepatoma cells transplanted into Buffalo rats or athymic mice.
Topics: Animals; Carcinoma, Hepatocellular; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Oligopeptides; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred BUF | 1992 |